Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s ...

Detailed price information for Twist Bioscience Corp (TWST-Q) from The Globe and Mail including charting and trades.

NRG Therapeutics, a fast growing neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, has ...

VANCOUVER, BC / ACCESS Newswire / December 1, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery ...

Twist Bioscience Corp (TWST) reported its Q4 2025 earnings, revealing a larger-than-expected loss per share (EPS) of $0.45 against a forecasted loss of $0.41. Despite this, the company exceeded ...

Twist Bioscience now appears more reasonably priced, which should lead to solid returns as fundamentals recover in H2 FY26.

Canadian-UK collaboration develops renewable bioplastic building blocks through advanced yeast fermentation for packaging ...

NRG Therapeutics Ltd. (“NRG”), an innovative neuroscience company targeting a novel mechanism to address mitochondrial dysfunction, is pleased to announce expansion of its team with the appointment of ...

Researchers from Turku Bioscience Center at the University of Turku, Finland, have developed a new computational method to ...

Twist reported SynBio revenue of $39.5 million for the quarter, a 17% increase year-over-year, and $145 million for the full year. NGS revenue reached $53 million for the quarter and $208.1 million ...

UB107 (BMP-2 Biomedical Material): A key growth factor in regenerative medicine, BMP-2 can be widely used clinically for bone defect reconstruction and spinal fusion surgery. It is expected to be ...